Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives
申请人:A. H. Robins Company, Incorporated
公开号:US05086055A1
公开(公告)日:1992-02-04
A method of treating allergic disorders and pharmaceutical compositions therefore are disclosed for a series of 5-[(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives of Formula I. These compounds are useful in inhibiting Type I allergic ##STR1## responses in a living animal and thus can be used to treat allergic phenomena such as asthma, rhinitis, atopic dermatitis, chronic hives, allergic conjunctivitis and the like.